KCNN4-mediated Ca2+/MET/AKT axis is promising for targeted therapy of pancreatic ductal adenocarcinoma.
Mo X, Zhang CF, Xu P, Ding M, Ma ZJ, Sun Q, Liu Y, Bi HK, Guo X, Abdelatty A, Hu C, Xu HJ, Zhou GR, Jia YL, Xia HP.
Mo X, et al. Among authors: ding m.
Acta Pharmacol Sin. 2022 Mar;43(3):735-746. doi: 10.1038/s41401-021-00688-3. Epub 2021 Jun 28.
Acta Pharmacol Sin. 2022.
PMID: 34183755
Free PMC article.